Andrea O Y Luk1, Eric M T Hui2, Ming-Chuen Sin3, Chun-Yip Yeung4, Wing-Sun Chow4, Andrew Y Y Ho5, Hin-Fai Hung6, Eva Kan7, Chiu-Ming Ng7, Wing-Yee So8, Chi-Kin Yeung9, Kin-Sang Chan10, Kin-Wah Chan6, Pang-Fai Chan11, Shing-Chung Siu12, Sau-Cheung Tiu7, Vincent T F Yeung13, Juliana C N Chan14, Frank W K Chan15, Clement Cheung15, Ngai-Tseung Cheung15, Siu-Tung Ho14, Karen S L Lam16, Linda W L Yu15, David Chao11, Ip-Tim Lau9. 1. Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong andrealuk@cuhk.edu.hk. 2. Department of Family Medicine, Prince of Wales Hospital, Hong Kong. 3. Department of Family Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong. 4. Department of Medicine, Queen Mary Hospital, Hong Kong. 5. Department of Medicine and Geriatrics, Tuen Mun Hospital, Hong Kong. 6. Department of Medicine and Geriatrics, Princess Margaret Hospital, Hong Kong. 7. Department of Medicine, Queen Elizabeth Hospital, Hong Kong. 8. Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong. 9. Department of Medicine, Tseung Kwan O Hospital, Hong Kong. 10. Department of Medicine, Haven of Hope Hospital, Hong Kong. 11. Department of Family Medicine and Primary Health Care, United Christian Hospital, Hong Kong. 12. Department of Medicine and Rehabilitation, Tung Wah Eastern Hospital, Hong Kong. 13. Department of Medicine and Geriatrics, Our Lady of Maryknoll Hospital, Hong Kong. 14. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong. 15. Hospital Authority, Hong Kong. 16. Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
Abstract
OBJECTIVE: Nationwide studies on secular trends of diabetes complications are not available in Asia. We examined changes in risk factor control and incidence of complications from diabetes and death in a large longitudinal cohort of Chinese adults with type 2 diabetes in Hong Kong. RESEARCH DESIGN AND METHODS: Between 1 January 2000 and 31 December 2012, 338,908 Chinese adults with type 2 diabetes underwent metabolic and complication assessment in 16 diabetes centers operated by Hong Kong Hospital Authority that provided care to a large majority of diagnosed patients. Patients were followed for incident acute myocardial infarction (AMI), stroke, end-stage renal disease (ESRD), and death until 31 December 2012. Risk factor levels between enrollment periods were compared. Incidence of clinical events, stratified by diabetes duration, was examined over time. RESULTS: Incidence of complications from diabetes and death declined over the observation period in patients at varying disease duration. Among the high-risk group with diabetes for at least 15 years, crude incidence of AMI decreased from 8.7 to 5.8, stroke from 13.5 to 10.1, ESRD from 25.8 to 22.5, and death from 29.0 to 26.6 per 1,000 person-year between the periods 2000 to 2002 and 2010 to 2012. Improvements in levels of metabolic risk factors were detected. Proportion of patients achieving HbA1c <7.0% (53 mmol/mol) was increased from 32.9 to 50.0%, blood pressure ≤130/80 mmHg from 24.7 to 30.7%, and LDL cholesterol <2.6 mmol/L from 25.8 to 38.1%. CONCLUSIONS: From this territory-wide Hong Kong Diabetes Database, we observed decreases in incidence of cardiovascular-renal complications and death and corresponding improvements in risk factor control over a 13-year period.
OBJECTIVE: Nationwide studies on secular trends of diabetes complications are not available in Asia. We examined changes in risk factor control and incidence of complications from diabetes and death in a large longitudinal cohort of Chinese adults with type 2 diabetes in Hong Kong. RESEARCH DESIGN AND METHODS: Between 1 January 2000 and 31 December 2012, 338,908 Chinese adults with type 2 diabetes underwent metabolic and complication assessment in 16 diabetes centers operated by Hong Kong Hospital Authority that provided care to a large majority of diagnosed patients. Patients were followed for incident acute myocardial infarction (AMI), stroke, end-stage renal disease (ESRD), and death until 31 December 2012. Risk factor levels between enrollment periods were compared. Incidence of clinical events, stratified by diabetes duration, was examined over time. RESULTS: Incidence of complications from diabetes and death declined over the observation period in patients at varying disease duration. Among the high-risk group with diabetes for at least 15 years, crude incidence of AMI decreased from 8.7 to 5.8, stroke from 13.5 to 10.1, ESRD from 25.8 to 22.5, and death from 29.0 to 26.6 per 1,000 person-year between the periods 2000 to 2002 and 2010 to 2012. Improvements in levels of metabolic risk factors were detected. Proportion of patients achieving HbA1c <7.0% (53 mmol/mol) was increased from 32.9 to 50.0%, blood pressure ≤130/80 mmHg from 24.7 to 30.7%, and LDL cholesterol <2.6 mmol/L from 25.8 to 38.1%. CONCLUSIONS: From this territory-wide Hong Kong Diabetes Database, we observed decreases in incidence of cardiovascular-renal complications and death and corresponding improvements in risk factor control over a 13-year period.
Authors: Jessica L Harding; Meda E Pavkov; Dianna J Magliano; Jonathan E Shaw; Edward W Gregg Journal: Diabetologia Date: 2018-08-31 Impact factor: 10.122
Authors: Lee Ling Lim; Eric S H Lau; Alice P S Kong; Melanie J Davies; Naomi S Levitt; Björn Eliasson; Carlos A Aguilar-Salinas; Guang Ning; Yutaka Seino; Wing Yee So; Margaret McGill; Graham D Ogle; Trevor J Orchard; Philip Clarke; Rury R Holman; Edward W Gregg; Juan José Gagliardino; Juliana C N Chan Journal: Diabetes Care Date: 2018-06 Impact factor: 19.112
Authors: Eugene Han; Sun Ok Song; Hye Soon Kim; Kang Ju Son; Sun Ha Jee; Bong-Soo Cha; Byung-Wan Lee Journal: Endocrinol Metab (Seoul) Date: 2022-06-29
Authors: Hongjiang Wu; Eric S H Lau; Ronald C W Ma; Alice P S Kong; Sarah H Wild; William Goggins; Elaine Chow; Wing-Yee So; Juliana C N Chan; Andrea O Y Luk Journal: Diabetologia Date: 2020-01-16 Impact factor: 10.122
Authors: Maria Narres; Heiner Claessen; Tatjana Kvitkina; Michael Koch; Lars Christian Rump; Thomas Weinreich; Andrea Icks Journal: Diabetologia Date: 2019-12-21 Impact factor: 10.122
Authors: Heiner Claessen; Maria Narres; Tatjana Kvitkina; Adrian Wilk; Heiko Friedel; Christian Günster; Falk Hoffmann; Michael Koch; Karin Jandeleit-Dahm; Andrea Icks Journal: Diabetes Care Date: 2021-05-04 Impact factor: 17.152